L’Oréal’s strategic venture capital fund, BOLD, has made a significant move by acquiring a minority stake in Timeline, a pioneering Swiss longevity biotech company. This investment highlights the growing intersection of beauty and longevity, with Timeline Venture Partners poised to revolutionize the industry through its groundbreaking scientific advancements. Founded in 2007 as a spin-off of the Swiss Federal Institute of Technology (EPFL) by Chris Rinsch and Patrick Aebischer, Timeline is dedicated to developing innovative longevity solutions applicable to the food, beauty, and health sectors.
At the heart of Timeline’s innovation is Mitopure®, a proprietary molecule designed to rejuvenate aging mitochondria – the cellular powerhouses. This technology, backed by over a decade of rigorous scientific research and numerous clinical studies, positions Timeline Venture Partners at the forefront of longevity science. L’Oréal’s investment will fuel Timeline’s continued technological development and operational expansion, paving the way for future collaborations and synergistic advancements in beauty and longevity.
Barbara Lavernos, Deputy Chief Executive Officer in charge of Research, Innovation and Technology at L’Oréal Groupe, emphasized the strategic importance of this investment. “Longevity is about living healthier for longer, and L’Oréal has been proactively exploring its implications for beauty for over a decade,” she stated. “Longevity introduces a transformative dimension to beauty, shifting the focus towards predicting, correcting, and even reversing the aging process of skin, scalp, and hair. Our investment in Timeline Venture Partners is particularly exciting due to its potential to translate the fundamental principles of longevity into tangible benefits for skin health and beauty.”
Patrick Aebischer, Co-Founder and Chairman of Timeline, echoed this sentiment, highlighting the collaborative potential of this partnership. “This strategic collaboration underscores the critical importance of a multidimensional approach, which we have always championed as essential for achieving meaningful progress in longevity and healthspan,” he commented. “I extend my gratitude to L’Oréal for their commitment to longevity solutions grounded in the highest caliber of science. This partnership with L’Oréal BOLD truly validates the Timeline Venture Partners vision.”
About L’Oréal
For over 110 years, L’Oréal has been a leader in the beauty industry, driven by a singular focus: fulfilling the diverse beauty aspirations of consumers worldwide. The company’s purpose is to “create the beauty that moves the world,” reflecting its commitment to inclusivity, ethics, generosity, and environmental and social sustainability. With a comprehensive portfolio of 37 international brands and ambitious sustainability goals under the “L’Oréal for the Future” program, L’Oréal offers a wide range of high-quality, effective, and responsible beauty solutions.
L’Oréal’s global presence is substantial, with 87,400 employees and sales across various distribution channels, including e-commerce, mass market, department stores, pharmacies, hair salons, and travel retail. In 2022, the Group generated sales of 38.26 billion euros. L’Oréal’s commitment to innovation is evident through its 20 research centers across 11 countries and a dedicated Research and Innovation team of over 4,000 scientists and 5,500 tech and digital professionals, solidifying its position as a Beauty Tech powerhouse inventing the future of beauty.
For more detailed information, please visit: https://www.loreal.com/en/mediaroom
About BOLD
BOLD, which stands for Business Opportunities for L’Oréal Development, is L’Oréal’s global corporate venture capital fund. Since its inception in 2018, BOLD has been at the forefront of beauty innovation, strategically investing in promising startups throughout the beauty value chain. BOLD’s investment portfolio includes both emerging brands and innovative companies in technology and biotechnology. This investment in Timeline Venture Partners further exemplifies BOLD’s commitment to pioneering advancements in the beauty and wellness sectors.
For more information about BOLD, please visit: www.lorealboldventures.com
About Timeline
Timeline, the consumer-facing brand of parent company Amazentis, is a Swiss health science company dedicated to revolutionizing longevity. Its flagship ingredient, Mitopure®, is clinically proven and proprietary, representing a breakthrough in cellular health. Timeline integrates Mitopure® into its next-generation nutritional supplements and topical skin health products, offering a comprehensive approach to combatting aging at the cellular level. With over 15 years of research in aging science, Timeline Venture Partners aims to extend human healthspan, enabling individuals to live longer and healthier lives. The company’s robust foundation includes over 50 patents, multiple clinical studies, and the backing of investors like Nestlé Health Science since 2019.
For more information, please visit: www.timelinenutrition.com
This strategic investment by L’Oréal BOLD in Timeline Venture Partners signals a significant step towards integrating longevity science into the beauty industry. By leveraging Timeline’s groundbreaking Mitopure® technology, L’Oréal is poised to explore new frontiers in anti-aging and cellular health, ultimately shaping the future of beauty.
